Distribution of capsule and O types in Klebsiella pneumoniae causing neonatal sepsis in Africa and South Asia: A meta-analysis of genome-predicted serotype prevalence to inform potential vaccine coverage
Verteilung von Kapsel- und O-Typen bei Klebsiella pneumoniae bei neonataler Sepsis in Afrika und Südasien: Metaanalyse der genomisch vorhergesagten Serotypprävalenz zur Abschätzung der potenziellen Impfstoffabdeckung
PLOS Medicine · 12.01.2026 · 23 (1) · e1004879
DOI: 10.1371/journal.pmed.1004879 ↗Auf einen Blick
Bei 1.930 Blutisolaten von Neugeborenen war die K- und O-Typ-Verteilung vielfältig. Ein 20-valenter K-Impfstoff könnte theoretisch ≥70 % der Infektionen in allen Zielregionen abdecken.
Fragestellung
Welche K- und O-Typen von K. pneumoniae sind bei neonataler Sepsis in Afrika und Südasien häufig, um eine potenzielle mütterliche Impfstoffabdeckung abzuschätzen?
Methode
Analyse von 1.930 K.-pneumoniae-Blutisolaten aus 13 Surveillance-Studien an 35 Standorten in 13 Ländern; Whole-Genome-Sequencing, bayesische hierarchische Metaanalyse.
Ergebnisse
87 K-Loci; KL2, KL102, KL25, KL15 und KL62 machten 49 % der Isolate aus. 20 K-Loci könnten 72,9 % aller Infektionen abdecken (95 %-CrI 69,4–76,5 %); die Top-5 O-Typen 86,2 % (82,6–89,9 %).
Einschränkungen
Abhängigkeit von Genomsequenzen zur Vorhersage von K- und O-Serotypen; keine serologische Typisierung; fehlende Längsschnittdaten zur zeitlichen Stabilität.
Schlussfolgerung der Autor:innen
Neonatale Sepsis war mit vielfältigen K- und O-Typen verbunden. Trotz geografischer und zeitlicher Variation könnte ein einzelner 20-valenter K-Impfstoff theoretisch ≥70 % der Infektionen in allen Zielregionen abdecken.
Kernaussagen
- 20 K-Loci könnten 72,9 % der Infektionen abdecken
- Top-5 O-Typen: 86,2 % Abdeckung
- Geografische und zeitliche Variation der Antigene
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Metaanalyse in der Zeitschrift PLOS Medicine, online erschienen am 12.01.2026. Verfasst von Thomas D Stanton und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, School of Translational Medicine, Monash University, Melbourne, Australia. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Neonatal Sepsis, Klebsiella Infections, O Antigens. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation, Wellcome Trust, Fleming Fund.
Themen: Sepsis
Abstract (Originalsprache)
Background
Klebsiella pneumoniae causes ~20% of sepsis in neonates, with ~40% crude mortality. A vaccine administered to pregnant women, protecting against ≥70% of K. pneumoniae infections, could avert ~400,000 cases and ~80,000 deaths annually, mostly in Africa and South Asia. Vaccine formulations targeting the capsular polysaccharide (K) or lipopolysaccharide (O) antigens are in development. Global K. pneumoniae populations display extensive K and O diversity, necessitating a polyvalent vaccine targeted to the serotypes associated with neonatal disease in relevant geographical regions. We investigated the prevalence of K and O types associated with neonatal sepsis in Africa and South Asia to inform maternal vaccine design. Methods and findings We analysed 1,930 K. pneumoniae neonate blood isolates from 13 surveillance studies across 35 sites in 13 countries. We used pathogen whole-genome sequencing to predict K and O serotypes and adjust for local transmission clusters, and Bayesian hierarchical meta-analysis to estimate K and O prevalence overall and per region, treating site as a random effect. Eighty-seven K loci were identified. KL2, KL102, KL25, KL15, and KL62 accounted for 49% of isolates. We estimate that 20 K loci, combining the eight most prevalent per region, could cover 72.9% of all infections (95% credible interval: [69.4%, 76.5%]) and ≥70% in each of Eastern, Western, and Southern Africa and South Asia. Preliminary findings from three sites suggested sufficient temporal stability of K loci to maintain 20-valent K vaccine coverage over 5–10 years, but more longitudinal data are needed to support this prediction. O types were far less diverse ( n = 14 types). We estimate the top-5 (O1⍺β,2⍺, O1⍺β,2β, O2⍺, O2β, and O4) would cover 86.2% [82.6, 89.9%] of total infections (76%–92% per region), while the top-10 would cover ~99% of infections in all four regions. The main limitations of our study are the reliance on genome sequences to predict K and O serotypes (as serological typing is not available) and a lack of longitudinal data to explore stability of antigen prevalence over time.
Conclusions
Neonatal sepsis is associated with diverse K and O types, with substantial geographic and temporal variation even after adjusting for localised transmission clusters. Despite this, a single 20-valent K vaccine could theoretically cover ≥70% of infections in all target regions. Locally-targeted vaccines could achieve higher coverage with lower valency, but are less feasible. In principle, very high coverage could be achieved with lower valency O-based vaccines, however, the protective efficacy against disease of antibodies targeting the O antigen remains uncertain. Further research is needed on cross-reactivity, antigen exposure, and stability of antigens over time, to better inform vaccine development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, School of Translational Medicine, Monash University, Melbourne, Australia.
- Centre to Impact AMR, Monash University, Clayton, Victoria, Australia.
- Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
- Department of Infectious Disease Epidemiology and International Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.
- Bioscience Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
- School of Natural Sciences, University of Lincoln, Lincoln, United Kingdom.
ORCID-Profile: Thomas D Stanton, Jabir A Abdulahi, Anne V Amulele, Matthew Bates, Eva Heinz, Kajal Jain, Rindidzani Magobo, Courtney P Olwagen, Jonathan Strysko, Caroline C Tigoi, Kyle Bittinger, Ebenezer Foster-Nyarko, Aneeta Hotwani, Naveed Iqbal, Furqan Kabir, Waqasuddin Khan, Chileshe L Musyani, Carolyn M McGann, Ahmed M Moustafa, Moreka L Ndumba, Erkison E Odih, Donwilliams O Omuoyo, Laura T Phillips, Aniqa Abdul Rasool, Charlene M C Rodrigues, Kirsty Sands, Arif M Tanmoy, Erin Theiller, Allan M Zuza, Kenneth C Iregbu, Semaria Solomon Alemayehu, Rabaab Zahra, Angela Dramowski, Sombo Fwoloshi, Lola Madrid, Noah Obeng-Nkrumah, Andrew C Whitelaw, Adhisivam Bethou
Förderung
- Gates Foundation
- Wellcome Trust
- Fleming Fund
- Penn Center for AIDS Research
- Thrasher Research Fund
- National Health and Medical Research Council
- Pfizer
Zitieren
APA
Stanton, T. D., Keegan, S. P., Abdulahi, J. A., Amulele, A. V., Bates, M., Heinz, E., Hooda, Y., Hu, W., Jain, K., Kanwar, S., Magobo, R., Olwagen, C. P., Tembo, J. M., Sonda, T., Strysko, J., Tigoi, C. C., Amin, S. A., Bittinger, K., Cornick, J., …, & Bethou, A. (2026). Distribution of capsule and O types in Klebsiella pneumoniae causing neonatal sepsis in Africa and South Asia: A meta-analysis of genome-predicted serotype prevalence to inform potential vaccine coverage. PLOS Medicine, 23(1), e1004879. https://doi.org/10.1371/journal.pmed.1004879
Vancouver
Stanton TD, Keegan SP, Abdulahi JA, Amulele AV, Bates M, Heinz E, et al. Distribution of capsule and O types in Klebsiella pneumoniae causing neonatal sepsis in Africa and South Asia: A meta-analysis of genome-predicted serotype prevalence to inform potential vaccine coverage. PLOS Medicine. 2026;23(1):e1004879. doi:10.1371/journal.pmed.1004879
BibTeX
@article{Stanton2026,
author = {Stanton, Thomas D and Keegan, Shaun P and Abdulahi, Jabir A and Amulele, Anne V and Bates, Matthew and Heinz, Eva and Hooda, Yogesh and Hu, Weiming and Jain, Kajal and Kanwar, Samiah and Magobo, Rindidzani and Olwagen, Courtney P and Tembo, John M and Sonda, Tolbert and Strysko, Jonathan and Tigoi, Caroline C and Amin, Sameen Ahmad and Bittinger, Kyle and Cornick, Jennifer and Foster-Nyarko, Ebenezer and Gumbi, Wilson and Hotwani, Aneeta and Iqbal, Naveed and Jones, Steven M and Kabir, Furqan and Khan, Waqasuddin and Musyani, Chileshe L and McGann, Carolyn M and Mittal, Varsha and Moustafa, Ahmed M and Musicha, Patrick and Mwansa, James C L and Ndumba, Moreka L and Odih, Erkison E and Omuoyo, Donwilliams O and Pearse, Oliver and Phillips, Laura T and Planet, Paul J and Rasool, Aniqa Abdul and Rodrigues, Charlene M C and Sands, Kirsty and Tanmoy, Arif M and Theiller, Erin and Zuza, Allan M and Basu, Sulagna and Chan, Grace J and Iregbu, Kenneth C and Mazarati, Jean-Baptiste and Alemayehu, Semaria Solomon and Walsh, Timothy R and Zahra, Rabaab and Dramowski, Angela and Fwoloshi, Sombo and Labi, Appiah-Korang and Madrid, Lola and Obeng-Nkrumah, Noah and Ojok, David and Wadugu, Boaz D and Whitelaw, Andrew C and Bethou, Adhisivam},
title = {Distribution of capsule and O types in Klebsiella pneumoniae causing neonatal sepsis in Africa and South Asia: A meta-analysis of genome-predicted serotype prevalence to inform potential vaccine coverage},
journal = {PLOS Medicine},
year = {2026},
volume = {23},
number = {1},
pages = {e1004879},
doi = {10.1371/journal.pmed.1004879}
}
EUVIMED